{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:01:49Z","timestamp":1784779309808,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1245\/s10434-020-08606-3","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T15:13:31Z","timestamp":1589901211000},"page":"4468-4473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of Sentinel Lymph Node Biopsy in Microinvasive Breast Cancer"],"prefix":"10.1245","volume":"27","author":[{"given":"Betty","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime A.","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amulya C.","family":"Alapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Szewczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"8606_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-015-0616-9","author":"L Orzalesi","year":"2016","unstructured":"Orzalesi L, Casella D, Criscenti V, et al. Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series. Breast Cancer. 2016. https:\/\/doi.org\/10.1007\/s12282-015-0616-9","journal-title":"Breast Cancer."},{"key":"8606_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13001","author":"TJ Lillemoe","year":"2018","unstructured":"Lillemoe TJ, Tsai ML, Swenson KK, et al. Clinicopathologic analysis of a large series of microinvasive breast cancers. Breast J. 2018. https:\/\/doi.org\/10.1111\/tbj.13001","journal-title":"Breast J."},{"key":"8606_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05200-4","author":"EV Holm-Rasmussen","year":"2019","unstructured":"Holm-Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF. Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study. Breast Cancer Res Treat. 2019. https:\/\/doi.org\/10.1007\/s10549-019-05200-4","journal-title":"Breast Cancer Res Treat"},{"key":"8606_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.10.020","author":"H Gojon","year":"2014","unstructured":"Gojon H, Fawunmi D, Valachis A. Sentinel lymph node biopsy in patients with microinvasive breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2014. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.020","journal-title":"Eur J Surg Oncol"},{"key":"8606_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.54","author":"MG Hanna","year":"2014","unstructured":"Hanna MG, Jaffer S, Bleiweiss IJ, Nayak A. Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma. Mod Pathol. 2014. https:\/\/doi.org\/10.1038\/modpathol.2014.54","journal-title":"Mod Pathol"},{"key":"8606_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.09.024","author":"L Costarelli","year":"2019","unstructured":"Costarelli L, Cianchetti E, Corsi F, et al. Microinvasive breast carcinoma: an analysis from ten Senonetwork Italia breast centres. Eur J Surg Oncol. 2019. https:\/\/doi.org\/10.1016\/j.ejso.2018.09.024","journal-title":"Eur J Surg Oncol"},{"key":"8606_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11079","author":"F Magnoni","year":"2019","unstructured":"Magnoni F, Massari G, Santomauro G, et al. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ. Br J Surg. 2019. https:\/\/doi.org\/10.1002\/bjs.11079","journal-title":"Br J Surg"},{"key":"8606_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013831","author":"S Bertozzi","year":"2019","unstructured":"Bertozzi S, Cedolini C, Londero AP, et al. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: retrospective observational study. Medicine (Baltimore). 2019. https:\/\/doi.org\/10.1097\/md.0000000000013831","journal-title":"Medicine (Baltimore)"},{"key":"8606_CR9","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2003.04.009","author":"M Intra","year":"2003","unstructured":"Intra M, Zurrida S, Maffini F, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol. 2003. https:\/\/doi.org\/10.1245\/aso.2003.04.009","journal-title":"Ann Surg Oncol"},{"key":"8606_CR10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1812-2","author":"BS Ko","year":"2012","unstructured":"Ko BS, Lim WS, Kim HJ, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer. Ann Surg Oncol. 2012. https:\/\/doi.org\/10.1245\/s10434-011-1812-2","journal-title":"Ann Surg Oncol"},{"key":"8606_CR11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07604-4","author":"A Phantana-angkool","year":"2019","unstructured":"Phantana-angkool A, Voci AE, Warren YE, et al. Ductal carcinoma in situ with microinvasion on core biopsy: Evaluating tumor upstaging rate, lymph node metastasis rate, and associated predictive variables. Ann Surg Oncol. 2019. https:\/\/doi.org\/10.1245\/s10434-019-07604-4","journal-title":"Ann Surg Oncol"},{"key":"8606_CR12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2376-5","author":"JM Lyons","year":"2012","unstructured":"Lyons JM, Stempel M, Van Zee KJ, Cody HS. Axillary node staging for microinvasive breast cancer: Is it justified? Ann Surg Oncol. 2012. https:\/\/doi.org\/10.1245\/s10434-012-2376-5","journal-title":"Ann Surg Oncol"},{"key":"8606_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2008.00594.x","author":"AA Guth","year":"2008","unstructured":"Guth AA, Mercado C, Roses DF, Darvishian F, Singh B, Cangiarella JF. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature. Breast J. 2008. https:\/\/doi.org\/10.1111\/j.1524-4741.2008.00594.x","journal-title":"Breast J."},{"key":"8606_CR14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3920-2","author":"CB Matsen","year":"2014","unstructured":"Matsen CB, Hirsch A, Eaton A, et al. Extent of Microinvasion in Ductal Carcinoma In Situ is not Associated with Sentinel Lymph Node Metastases. Ann Surg Oncol. 2014. https:\/\/doi.org\/10.1245\/s10434-014-3920-2","journal-title":"Ann Surg Oncol"},{"key":"8606_CR15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.228","author":"AD Purushotham","year":"2005","unstructured":"Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005. https:\/\/doi.org\/10.1200\/jco.2005.03.228","journal-title":"J Clin Oncol."},{"key":"8606_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.138.5.482","author":"DK Blanchard","year":"2003","unstructured":"Blanchard DK, Donohue JH, Reynolds C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Archives of Surgery (2003). https:\/\/doi.org\/10.1001\/archsurg.138.5.482","journal-title":"Archives of Surgery"},{"key":"8606_CR17","unstructured":"Breast Cancer. National Comprehensive Cancer Network. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. March 6, 2020. Accessed: April 20, 2020."},{"key":"8606_CR18","unstructured":"Amin MB, Edge S, Greene F, et al. (Eds.). AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer. 2017."},{"key":"8606_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3027-2","author":"AR Keruakous","year":"2014","unstructured":"Keruakous AR, Sadek BT, Shenouda MN, et al. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy. Breast Cancer Res Treat. 2014. https:\/\/doi.org\/10.1007\/s10549-014-3027-2","journal-title":"Breast Cancer Res Treat"},{"key":"8606_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4015-5","author":"J Iqbal","year":"2017","unstructured":"Iqbal J, Ginsburg O, Giannakeas V, Rochon PA, Semple JL, Narod SA. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer. Breast Cancer Res Treat. 2017. https:\/\/doi.org\/10.1007\/s10549-016-4015-5","journal-title":"Breast Cancer Res Treat."},{"key":"8606_CR21","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9513-6","author":"SL Chen","year":"2007","unstructured":"Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007. https:\/\/doi.org\/10.1245\/s10434-007-9513-6","journal-title":"Ann Surg Oncol."},{"key":"8606_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2007.08.024","author":"CE Cox","year":"2008","unstructured":"Cox CE, Kiluk J\u00a0V., Riker AI, et al. Significance of sentinel lymph node micrometastases in Human Breast Cancer. J Am Coll Surg. 2008. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.08.024","journal-title":"J Am Coll Surg"},{"key":"8606_CR23","doi-asserted-by":"publisher","unstructured":"van der Heiden-van der Loo M, Schaapveld M, Ho VKY, Siesling S, Rutgers EJT, Peeters PHM. Outcomes of a population-based series of early breast cancer patients with micrometastases and isolated tumour cells in axillary lymph nodes. Ann Oncol. 2013. https:\/\/doi.org\/10.1093\/annonc\/mdt243","DOI":"10.1093\/annonc\/mdt243"},{"key":"8606_CR24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.5001","author":"Y Andersson","year":"2010","unstructured":"Andersson Y, Frisell J, Sylvan M, De Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol. 2010. https:\/\/doi.org\/10.1200\/jco.2009.24.5001","journal-title":"J Clin Oncol"},{"key":"8606_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.12.020","author":"K Lupe","year":"2011","unstructured":"Lupe K, Truong PT, Alexander C, Speers C, Tyldesley S. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Int J Radiat Oncol Biol Phys. 2011. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"8606_CR26","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i2.243","author":"A Tallet","year":"2016","unstructured":"Tallet A, Lambaudie E, Cohen M, et al. Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy. World J Clin Oncol. 2016. https:\/\/doi.org\/10.5306\/wjco.v7.i2.243","journal-title":"World J Clin Oncol."},{"issue":"1","key":"8606_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6417-3","volume":"19","author":"KH Lee","year":"2019","unstructured":"Lee KH, Han JW, Kim EY, Yun JS, Park YL, Park CH. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy. BMC Cancer. 2019;19(1):1-8. https:\/\/doi.org\/10.1186\/s12885-019-6417-3","journal-title":"BMC Cancer."},{"issue":"9","key":"8606_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41416-018-0276-6","volume":"119","author":"CJC Meurs","year":"2018","unstructured":"Meurs CJC, van Rosmalen J, Menke-Pluijmers MBE, et al. A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers. Br J Cancer. 2018;119(9):1155-1162. https:\/\/doi.org\/10.1038\/s41416-018-0276-6","journal-title":"Br J Cancer."},{"key":"8606_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2017.12.007","author":"AJ Maxwell","year":"2018","unstructured":"Maxwell AJ, Clements K, Hilton B, et al. Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. Eur J Surg Oncol. 2018. https:\/\/doi.org\/10.1016\/j.ejso.2017.12.007","journal-title":"Eur J Surg Oncol."},{"key":"8606_CR30","unstructured":"Collins LC, Laronga C, Wong, JS. Microinvasive breast carcinoma.\u00a0UpToDate. Waltham, MA: UpToDate; 2019. www.uptodate.com. Accessed March 30, 2020."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08606-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T23:26:47Z","timestamp":1621380407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["8606"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08606-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"11 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Ted James is a scientific consultant for Perimeter Medical.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}